Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL1481982

O=C(O)C(F)(F)F.O=Cc1ccc(C=CC(=O)O)nc1

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P4HTM Q9NXG6 1/20 0.46
HDAC3 O15379 3/20 0.40
HDAC4 P56524 3/20 0.40
HDAC1 Q13547 3/20 0.40
HDAC7 Q8WUI4 3/20 0.40
HDAC2 Q92769 3/20 0.40
HDAC10 Q969S8 3/20 0.40
HDAC11 Q96DB2 3/20 0.40
HDAC8 Q9BY41 3/20 0.40
HDAC6 Q9UBN7 3/20 0.40
HDAC9 Q9UKV0 3/20 0.40
HDAC5 Q9UQL6 3/20 0.40
TBXAS1 P24557 2/20 0.40
RAB9A P51151 1/20 0.39
KDM4E B2RXH2 8/20 0.39
LMNA P02545 2/20 0.39
HCAR2 Q8TDS4 2/20 0.39
CA12 O43570 2/20 0.39
AKR1B10 O60218 2/20 0.39
CA1 P00915 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL1481977 1.00 P4HTM (0.46) P4HTMHDAC3HDAC4HDAC1HDAC7
SCHEMBL1481960 0.91 P4HTM (0.54) P4HTMHDAC3HDAC4HDAC1HDAC7
SCHEMBL1481958 0.91 P4HTM (0.54) P4HTMHDAC3HDAC4HDAC1HDAC7
Trifluoroacetic Acid SCHEMBL1970993 0.81 KDM4E (0.41) P4HTMHDAC3HDAC4HDAC1HDAC7
Trifluoroacetic Acid SCHEMBL1970997 0.81 KDM4E (0.41) P4HTMHDAC3HDAC4HDAC1HDAC7
Trifluoroacetic Acid SCHEMBL1321616 0.81 HDAC3 (0.65) P4HTMHDAC3HDAC4HDAC1HDAC7
Trifluoroacetic Acid SCHEMBL1321618 0.81 HDAC3 (0.65) P4HTMHDAC3HDAC4HDAC1HDAC7
SCHEMBL11660064 0.80 P4HTM (0.68) P4HTMHDAC3HDAC4HDAC1HDAC7
SCHEMBL11660063 0.80 P4HTM (0.68) P4HTMHDAC3HDAC4HDAC1HDAC7
Trifluoroacetic Acid SCHEMBL732103 0.80 NFE2L2 (0.42) P4HTMHDAC3HDAC4HDAC1HDAC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8242175-B2 Class of histone deacetylase inhibitors DAC S.R.L. (IT) 2012-08-14 US disclosed
US-20110077247-A1 CLASS OF HISTONE DEACETYLASE INHIBITORS DAC S.r.I. (IT) 2011-03-31 US disclosed
EP-2049508-B1 N-HYDROXY-3-(4-{3-PHENYL-3-OXO-PROPENYL}-PHENYL)-ACRYLAMIDE DERIVATIVES AND RELATED COMPOUNDS AS HISTONE DEACETYLASE INHIBITORS FOR THE TREATMENT OF CANCER DAC SRL (IT) 2010-06-09 EP disclosed
US-20100113438-A1 CLASS OF HISTONE DEACETYLASE INHIBITORS DAC S.R.L. (IT) 2010-05-06 US disclosed
EP-2049508-A2 N-HYDROXY-3-(4-{3-PHENYL-3-OXO-PROPENYL}-PHENYL)-ACRYLAMIDE DERIVATIVES AND RELATED COMPOUNDS AS HISTONE DEACETYLASE INHIBITORS FOR THE TREATMENT OF CANCER DAC S.r.l. (IT) 2009-04-22 EP disclosed
WO-2007113249-A2 N-HYDROXY-3-(4-{3-PHENYL-S-OXO-PROPENYL}-PHENYL)-ACRYLAMIDE DERIVATIVES AND RELATED COMPOUNDS AS HISTONE DEACETYLASE INHIBITORS FOR THE TREATMENT OF CANCER DAC S.R.L. (IT) 2007-10-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110077247-A1 CLASS OF HISTONE DEACETYLASE INHIBITORS HDAC3, HDAC1, HDAC11 P4HTM 1102/4885HDAC3 1/4885HDAC4 5/4885
US-20100113438-A1 CLASS OF HISTONE DEACETYLASE INHIBITORS HDAC3, HDAC1, HDAC11 P4HTM 1102/4885HDAC3 1/4885HDAC4 5/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.